4.7 Article

New role of the human equilibrative nucleoside transporter 1 (hENT1) in Epithelial-to-mesenchymal transition in renal tubular cells

期刊

JOURNAL OF CELLULAR PHYSIOLOGY
卷 227, 期 4, 页码 1521-1528

出版社

WILEY
DOI: 10.1002/jcp.22869

关键词

-

资金

  1. Generalitat de Catalunya [2009SGR1116, 2009SGR624]
  2. Fundacion Renal Inigo Alvarez de Toledo (FRIAT)
  3. Ministerio de Ciencia e Innovacion [SAF2008-00577]
  4. Biomedical Research Institut Network - Liver and Gastrointestinal Diseases (CIBER EHD)

向作者/读者索取更多资源

Epithelial-to-mesenchymal transition (EMT) is an important pro-fibrotic event in which tubular epithelial cells are transformed into myofibroblasts. Nucleoside transporters (NT) are regulated by many factors and processes, some of which are involved in fibrosis, such as cytokines, inflammation, and proliferation. Equilibrative nucleoside transporter 1 (ENT1) has been proved to be the most widely expressed adenosine transporter. In that sense, ENT1 may be a key player in cell damage signaling. Here we analyze the role of human ENT1 (hENT1) in the EMT process in proximal tubular cells. Addition of the main inducer of EMT, the transforming growth factor-beta 1, to HK-2 cells increased hENT1 mRNA and protein level expression. ENT1-mediated adenosine uptake was also enhanced. When cells were incubated with dipyridamole to evaluate the potential contribution of ENT1 to EMT by blocking its transport activity, EMT was induced. Moreover, the knock down of hENT1 with siRNA induced EMT and collagen production in HK-2 cells. Kidneys isolated from ENT1 knockout mice showed higher levels of interstitial collagen and a-SMA positive cells than wild-type mice. Our results point to a new potential role of hENT1 as a modulator of EMT in proximal tubular cells. In this sense, hENT1 could be involved in renal protection processes, and the loss or reduced expression of hENT1 would lead to an increased vulnerability of cells to the onset and/or progression of renal fibrosis. J. Cell. Physiol. 227: 1521-1528, 2012. (C) 2011 Wiley Periodicals, Inc.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Urology & Nephrology

Validation of a Histologic Scoring Index for C3 Glomerulopathy

Fernando Caravaca-Fontan, Hernando Trujillo, Marina Alonso, Montserrat Diaz-Encarnacion, Virginia Cabello, Gema Ariceta, Luis F. Quintana, Helena Marco, Xoana Barros, Natalia Ramos, Nuria Rodriguez-Mendiola, Sonia Cruz, Gema Fernandez-Juarez, Eva Rodriguez, Francisco de la Cerda, Ana Perez de Jose, Inmaculada Lopez, Loreto Fernandez, Vanessa Perez Gomez, Ana Avila, Luis Bravo, Javier Lumbreras, Natalia Allende, Maria Dolores Sanchez de la Nieta, Teresa Olea, Marta Melgosa, Ana Huerta, Rosa Miquel, Carmen Mon, Gloria Fraga, Alberto de Lorenzo, Juliana Draibe, Fayna Gonzalez, Amir Shabaka, Maria Luisa Illescas, Consuelo Calvo, Victoria Oviedo, Iara Da Silva, Elena Goicoechea de Jorge, Francisco Caravaca, Manuel Praga

Summary: The study validated the performance of C3G-HI as a predictor of kidney failure in patients with C3G, with the total chronicity score identified as the principal histologic correlate of kidney failure.

AMERICAN JOURNAL OF KIDNEY DISEASES (2021)

Article Biochemistry & Molecular Biology

Unexpected obesity, rather than tumorigenesis, in a conditional mouse model of mitochondrial complex II deficiency

Fatimah Al Khazal, Seungwoo Kang, Molly Nelson Holte, Doo-Sup Choi, Ravinder Singh, Patricia Ortega-Saenz, Jose Lopez-Barneo, L. James Maher

Summary: Mutations in genes encoding the subunits of succinate dehydrogenase can cause various disorders, including hereditary tumors. However, loss of SDHC did not result in PPGL in mice, but instead caused non-diabetic obesity.

FASEB JOURNAL (2021)

Article Medicine, General & Internal

Avacopan for the Treatment of ANCA-Associated Vasculitis

David R. W. Jayne, Peter A. Merkel, Thomas J. Schall, Pirow Bekker

Summary: In this study, the C5a receptor inhibitor avacopan was found to be noninferior to prednisone taper in achieving remission at week 26, but superior in achieving sustained remission at week 52 in patients with ANCA-associated vasculitis. All patients received cyclophosphamide or rituximab. The safety and clinical effects of avacopan beyond 52 weeks were not addressed in the trial.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Transplantation

Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy

Fernando Caravaca-Fontan, Montserrat Diaz-Encarnacion, Virginia Cabello, Gema Ariceta, Luis F. Quintana, Helena Marco, Xoana Barros, Natalia Ramos, Nuria Rodriguez-Mendiola, Sonia Cruz, Gema Fernandez-Juarez, Adela Rodriguez, Ana Perez de Jose, Cristina Rabasco, Raquel Rodado, Loreto Fernandez, Vanessa Perez Gomez, Ana avila, Luis Bravo, Natalia Espinosa, Natalia Allende, Maria Dolores Sanchez de la Nieta, Eva Rodriguez, Teresa Olea, Marta Melgosa, Ana Huerta, Rosa Miquel, Carmen Mon, Gloria Fraga, Alberto de Lorenzo, Juliana Draibe, Marta Cano-Megias, Fayna Gonzalez, Amir Shabaka, Maria Esperanza Lopez-Rubio, Maria Angeles Fenollosa, Luis Martin-Penagos, Iara Da Silva, Juana Alonso Titos, Santiago Rodriguez de Cordoba, Elena Goicoechea de Jorge, Manuel Praga

Summary: The longitudinal change in proteinuria is strongly associated with the risk of kidney failure in patients with C3 glomerulopathy, with a doubling of proteinuria levels resulting in a 2.5-fold increase in risk. A ≥50% reduction in proteinuria over time is significantly associated with a lower risk of kidney failure.

NEPHROLOGY DIALYSIS TRANSPLANTATION (2022)

Review Clinical Neurology

Emerging Nondopaminergic Medications for Parkinson's Disease: Focusing on A2A Receptor Antagonists and GLP1 Receptor Agonists

Pei Shang, Matthew Baker, Samantha Banks, Sa-Ik Hong, Doo-Sup Chol

Summary: A(2A)R antagonists and GLP1R agonists may have potential roles in the management of Parkinson's disease, with the former reducing dyskinesia and the latter alleviating neuroinflammation and sustaining cellular functions in the central nervous system.

JOURNAL OF MOVEMENT DISORDERS (2021)

Article Biochemistry & Molecular Biology

OncomiRs miR-106a and miR-17 negatively regulate the nucleoside-derived drug transporter hCNT1

Clara Boces-Pascual, Aida Mata-Ventosa, Mireia Martin-Satue, Loreto Boix, Meritxell Gironella, Marcal Pastor-Anglada, Sandra Perez-Torras

Summary: Downregulation of hCNT1 protein was found in both colorectal and pancreatic ductal adenocarcinoma, potentially regulated by miR-106a and miR-17, leading to chemoresistance to fluoropyrimidine-based treatments.

CELLULAR AND MOLECULAR LIFE SCIENCES (2021)

Article Neurosciences

N-6-substituated adenosine analog J4 attenuates anxiety-like behaviors in mice

Lee Peyton, Brandon Emanuel Leon, Hesham Essa, Yijuang Chern, Doo-Sup Choi

Summary: This study investigates the effects of J4, an adenosine analog, on alleviating alcohol withdrawal-related affective behaviors. The results show that J4 treatment reduces anxiety-like behavior and increases time spent in open arms, suggesting its potential as a general anxiolytic.

PSYCHOPHARMACOLOGY (2022)

Review Biochemistry & Molecular Biology

Inborn Errors of Nucleoside Transporter (NT)-Encoding Genes (SLC28 and SLC29)

Marcal Pastor-Anglada, Aida Mata-Ventosa, Sandra Perez-Torras

Summary: The regulation of nucleotide pools is crucial for cellular functions. Mutations in genes encoding nucleoside and nucleobase transporters have been identified in certain rare diseases, causing various clinical manifestations. Understanding the physiological and molecular features of these transporter proteins helps in understanding the biochemical and clinical effects of these deficiencies.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Review Pharmacology & Pharmacy

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics

Merce Brunet, Marcal Pastor-Anglada

Summary: The influence of pharmacogenetics in tacrolimus pharmacokinetics and pharmacodynamics needs further investigation to assist in predicting optimal dosage, personalized adjustment of the dose, and identifying high-risk patients. New strategies have been developed to improve personalized tacrolimus treatment, with lower doses associated with higher incidence of adverse events. Inconsistent genotype-phenotype relationships have been identified in tacrolimus pharmacodynamics.

PHARMACEUTICS (2022)

Article Chemistry, Multidisciplinary

Chronic Intermittent Ethanol Exposure Alters Behavioral Flexibility in Aged Rats Compared to Adult Rats and Modifies Protein and Protein Pathways Related to Alzheimer's Disease

Ada Man-Choi Ho, Mina P. Peyton, Samantha J. Scaletty, Sarah Trapp, Areonna Schreiber, Benjamin J. Madden, Doo-Sup Choi, Douglas B. Matthews

Summary: Repeated excessive alcohol consumption increases the risk of cognitive decline and dementia in older adults. This study found that chronic intermittent ethanol exposure impaired behavioral flexibility in aged rats but not in young adult rats. Proteomic analysis revealed alcohol treatment-related changes in proteins and pathways associated with neural transmission, synaptic plasticity, neuronal apoptosis, and insulin receptor signaling. These findings contribute to understanding the detrimental effects of alcohol on cognitive function in older adults.

ACS OMEGA (2022)

Article Neurosciences

A novel monobactam lacking antimicrobial activity, MC-100093, reduces sex-specific ethanol preference and depressive-like behaviors in mice

Brandon Emanuel Leon, Lee Peyton, Hesham Essa, Tia Wieden, Nicole Marion, Wayne E. Childers, Magid Abou-Gharbia, Doo-Sup Choi

Summary: The study found that MC-100093 treatment has positive effects on depressive behaviors and ethanol consumption in female mice, but no significant effects in male mice. In addition, MC-100093 treatment reduces female preference for 10% ethanol. Western blot analysis of the medial prefrontal cortex and hippocampus revealed no changes in GLT1 protein abundance in both male and female mice.

NEUROPHARMACOLOGY (2023)

Article Multidisciplinary Sciences

External globus pallidus input to the dorsal striatum regulates habitual seeking behavior in male mice

Matthew Baker, Seungwoo Kang, Sa-Ik Hong, Minryung Song, Minsu Abel Yang, Lee Peyton, Hesham Essa, Sang Wan Lee, Doo-Sup Choi

Summary: The authors found that GPe arky neurons are involved in reward-seeking behaviors and primarily project to the dorsolateral striatum. Genetic ablation of this circuit shift behavior from goal-directed to habitual seeking.

NATURE COMMUNICATIONS (2023)

Article Chemistry, Medicinal

Sustained Release GLP-1 Agonist PT320 Delays Disease Progression in a Mouse Model of Parkinson's Disease

Vicki Wang, Tung-Tai Kuo, Eagle Yi-Kung Huang, Kuo-Hsing Ma, Yu-Ching Chou, Zhao-Yang Fu, Li-Wen Lai, Jin Jung, Hoi- Choi, Doo-Sup Choi, Yazhou Li, Lars Olson, Nigel H. Greig, Barry J. Hoffer, Yuan-Hao Chen

Summary: GLP-1 agonists, such as PT320, show potential in improving behavioral and cellular parameters in a mouse model of Parkinson's disease (PD), particularly in the early stages of the disease. The efficacy may be closely related to enhanced dopamine midbrain function.

ACS PHARMACOLOGY & TRANSLATIONAL SCIENCE (2021)

暂无数据